Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2000 1
2001 1
2004 3
2005 4
2006 5
2007 8
2008 4
2009 6
2010 6
2011 4
2012 7
2013 8
2014 11
2015 1
2016 2
2017 1
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 24611562

67 results
Results by year
Filters applied: . Clear all
Page 1
Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy.
Ito T, Urushima H, Sakaue M, Yukawa S, Honda H, Hirai K, Igura T, Hayashi N, Maeda K, Kitagawa T, Kondo K. Ito T, et al. Nutr Cancer. 2014;66(3):377-82. doi: 10.1080/01635581.2014.884232. Epub 2014 Mar 10. Nutr Cancer. 2014. PMID: 24611562 Clinical Trial.
The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI. Hirose A, et al. Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. doi: 10.1016/j.taap.2007.03.031. Epub 2007 Apr 20. Toxicol Appl Pharmacol. 2007. PMID: 17555784
Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.
Yanagimoto H, Satoi S, Yamamoto T, Hirooka S, Yamaki S, Kotsuka M, Ryota H, Michiura T, Inoue K, Matsui Y, Tsuta K, Kon M. Yanagimoto H, et al. Nutr Cancer. 2016;68(2):234-40. doi: 10.1080/01635581.2016.1134597. Epub 2016 Feb 4. Nutr Cancer. 2016. PMID: 26847832 Clinical Trial.
The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based Chemotherapy.
Suknikhom W, Lertkhachonsuk R, Manchana T. Suknikhom W, et al. Asian Pac J Cancer Prev. 2017 Mar 1;18(3):633-638. doi: 10.22034/APJCP.2017.18.3.633. Asian Pac J Cancer Prev. 2017. PMID: 28440968 Free PMC article.
Effect of active hexose-correlated compound in women receiving adjuvant chemotherapy for breast cancer: a retrospective study.
Hangai S, Iwase S, Kawaguchi T, Kogure Y, Miyaji T, Matsunaga T, Nagumo Y, Yamaguchi T. Hangai S, et al. J Altern Complement Med. 2013 Nov;19(11):905-10. doi: 10.1089/acm.2012.0914. Epub 2013 Jul 5. J Altern Complement Med. 2013. PMID: 23829813 Free PMC article.
Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.
Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. Shigama K, et al. J Exp Ther Oncol. 2009;8(1):43-51. J Exp Ther Oncol. 2009. PMID: 19827270
[Chronic fatigue syndrome and herpesvirus reactivation].
Kondo K. Kondo K. Nihon Rinsho. 2007 Jun;65(6):1043-8. Nihon Rinsho. 2007. PMID: 17561695 Review. Japanese.
Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment.
Cowawintaweewat S, Manoromana S, Sriplung H, Khuhaprema T, Tongtawe P, Tapchaisri P, Chaicumpa W. Cowawintaweewat S, et al. Asian Pac J Allergy Immunol. 2006 Mar;24(1):33-45. Asian Pac J Allergy Immunol. 2006. PMID: 16913187 Free article. Clinical Trial.
Health-related quality of life in early breast cancer.
Groenvold M. Groenvold M. Dan Med Bull. 2010 Sep;57(9):B4184. Dan Med Bull. 2010. PMID: 20816024
Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity.
Höllsberg P, Kusk M, Bech E, Hansen HJ, Jakobsen J, Haahr S. Höllsberg P, et al. Acta Neurol Scand. 2005 Dec;112(6):395-402. doi: 10.1111/j.1600-0404.2005.00516.x. Acta Neurol Scand. 2005. PMID: 16281923 Clinical Trial.
67 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page